| |
Rescentris Leadership
Leonore A. Herzenberg, Ph.D.
Michael Muller
Jeff Spitzner, Ph.D.
Joseph Spitzner, Ph.D.
Leonard A. Herzenberg, Ph.D.
Lorie Karnath, MBA
Leonore A. Herzenberg, Ph.D.
Board of Directors, Rescentris
Dr. Herzenberg is an internationally recognized geneticist and immunologist, Lee has made seminal contributions both to the understanding of basic regulatory immunology and lymphocyte biology and to the development of monoclonal antibody technology for pre-clinical and clinical studies.
Dr. Herzenberg’s contributions to immunology and flow cytometry technology have been recognized with the Torino Medical Award, which she shared with Len Herzenberg in 2007. Lee has authored over 450 scientific papers. She maintains a direct relationship with manufacturers of FACS technology and is currently a member of the Invitrogen Scientific Advisory Board. Lee has made major design contributions to companies, including ScienceXperts and Woodside Logic. Lee has a Doctorat d’Etat-es-Sciences, from the Sorbonne.
 top
Michael Muller
Board of Directors, Rescentris
Mr. Muller has been an entrepreneur, manager, technologist and innovator in the computer industry for 25 years. He co-founded NextMonet, which to provides an informative context for consumers to discover and purchase contemporary art. Mr. Muller also founded CONNECT, Inc., where served as President, CEO. Previously he was President of Apple Computer Information Services and VP and GM of the Apple Computer’s Accessory Product Division. Mr. Muller has a Bachelor of Science degree in Physics Technology from the Polytechnicum of Iserlohn, Germany.
top
Jeff Spitzner, Ph.D.
President, Chief Science Officer, Rescentris
Board of Directors, Rescentris
Dr. Spitzner has more than 20 years experience founding and managing scientific software and biotechnology companies and is a recognized leader in electronic lab notebooks (ELNs), bioinformatics, and knowledge management. He serves as Adjunct Assistant Professor of Biomedical Informatics, The Ohio State University. He received his Ph.D. in Molecular Biology from The Ohio State University, then conducted postdoctoral studies on DNA-protein interactions and molecular cancer research at MIT. In 1997 Dr. Spitzner co-authored data standards for integrating and exchanging genome research information that resulted in the development of BSML as the pioneering XML technology and data standard in the life sciences.
top
Joseph Spitzner, Ph.D.
Chief Technical Officer, Rescentris
Board of Directors, Rescentris
Dr. Spitzner is the designer and chief architect for all of Rescentris’ software products. He is a leading expert in the development of innovative semantic web technology based software systems, including CERF and Science Desktop™. Dr. Spitzner has been an innovator in scientific software and data analysis since 1965. He received a Ph.D. in Experimental Psychology from Rutgers University in 1968 and taught at The Ohio State University from 1968-1973. From 1973 to 1990, Dr. Spitzner was a business consultant specializing in information science and software applications for data analysis.
In 1997 he was Principal Investigator on an NIH grant to develop standards for integrating and visualizing genome research data. Dr. Spitzner was a founder of the bioinformatics firm Visual Genomics and brought XML/BSML technology to Rescentris. Dr, Spitzner has extensive experience in project management and has led software development efforts and contracts for services at a number of pharmaceutical clients. Dr. Spitzner received a CIO of the year award as one of the top 100 Chief Information Officers in the USA in 2001.
top
Leonard A. Herzenberg, Ph.D.
Scientific Advisor, Rescenris
Widely known as one of the pioneers of modern biotechnology, Len headed the team that developed the Fluorescence Activated Cell Sorter (FACS) at Stanford University. He helped found what is now Becton-Dickinson Biosciences, the leading manufacturer of FACS systems, and has recently agreed to head the Invitrogen Science Advisory Board for flow cytometry.
Len also pioneered the use of monoclonal antibodies as reagents for FACS and other medical technologies. Emeritus Professor of Genetics at Stanford University Medical School, Len has contributed greatly to understanding the immune system and has trained many of the leading scientists in the field. The National Academy of Sciences elected him to membership in 1982 and several top scientific prizes have recognized his work. These include the Torino Medical Award (2007), Kyoto Prize (2006), Novartis Award in Immunology (2004), the Edwin D. Ullman Award in Clinical Chemistry (2002) and the the Lifetime Service Award of the American Association of Immunologists (1998).
top
Lorie Karnath, MBAChair of Rescentris’ Scientific Advisory Board, and Managing Director, International.
Ms. Karnath is based in Berlin, Germany and has extensive experience in finance and investment banking, focusing on the life sciences arena. She served six years on the board of the National Foundation for Cancer Research, she is the representative for the Nobel Laureates in Lindau, and serves on a number of other boards and committees. Ms. Karnath has been Senior Vice President in charge of Germany’s Industrial Investment Council’s North American operations, VP and Corporate Officer of The Stride Rite Corporation, where she headed Mergers & Acquisitions and other strategic divisions, Manager at a scientific software company, and in international M&A for Credit Suisse and Kidder Peabody. She has published many articles and books, is President of the Explorers Club, and has written extensively on knowledge management. She has her BA in Biology and her MBA from INSEAD.
top
|
|
|
|